Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
3.47
USD
|
-0.86%
|
|
+0.29%
|
-11.48%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
113
|
150.8
|
86.81
|
84.83
|
114.8
|
102.1
|
Enterprise Value (EV)
1 |
113
|
150.8
|
86.81
|
84.83
|
114.8
|
102.1
|
P/E ratio
|
-
|
-
|
-2.69
x
|
-1.96
x
|
4.5
x
|
174
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
2.84
x
|
2.01
x
|
0.62
x
|
0.61
x
|
0.48
x
|
EV / Revenue
|
-
|
2.84
x
|
2.01
x
|
0.62
x
|
0.61
x
|
0.48
x
|
EV / EBITDA
|
-3.24
x
|
-
|
-3.87
x
|
-3.24
x
|
77.1
x
|
9.13
x
|
EV / FCF
|
-
|
-
|
-3,359,504
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-0%
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
9,413
|
11,911
|
12,804
|
12,623
|
29,279
|
29,412
|
Reference price
2 |
12.00
|
12.66
|
6.780
|
6.720
|
3.920
|
3.470
|
Announcement Date
|
-
|
3/16/21
|
3/31/22
|
3/20/23
|
3/12/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
-
|
53.14
|
43.27
|
136.1
|
188.1
|
214.8
|
EBITDA
1 |
-34.82
|
-
|
-22.45
|
-26.17
|
1.488
|
11.18
|
EBIT
1 |
-
|
-
|
-31.46
|
-
|
23.22
|
0.877
|
Operating Margin
|
-
|
-
|
-72.7%
|
-
|
12.35%
|
0.41%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-30.57
|
-42.33
|
24.86
|
0.572
|
Net income
1 |
-
|
-136.4
|
-30.53
|
-
|
24.71
|
0.572
|
Net margin
|
-
|
-256.77%
|
-70.55%
|
-
|
13.14%
|
0.27%
|
EPS
2 |
-
|
-
|
-2.520
|
-3.420
|
0.8709
|
0.0200
|
Free Cash Flow
|
-
|
-
|
-25.84
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-59.72%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
-
|
3/16/21
|
3/31/22
|
3/20/23
|
3/12/24
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
|
10.18
|
12.15
|
12.88
|
-
|
-
|
48.22
|
48.01
|
50.59
|
47.27
|
42.19
|
-
|
EBITDA
1 |
-6.754
|
-8.111
|
-6.781
|
-7.242
|
-8.402
|
-5.079
|
-3.851
|
-2.004
|
3.392
|
3.953
|
2.4
|
EBIT
|
-7.001
|
-16.38
|
-6.976
|
-
|
-
|
-
|
-
|
0.672
|
1.619
|
2.42
|
-
|
Operating Margin
|
-68.78%
|
-134.79%
|
-54.17%
|
-
|
-
|
-
|
-
|
1.33%
|
3.43%
|
5.74%
|
-
|
Earnings before Tax (EBT)
|
0.512
|
-16.26
|
-10.73
|
-
|
-
|
-19.15
|
-
|
-0.014
|
1.368
|
2.156
|
-
|
Net income
|
0.509
|
-16.19
|
-10.72
|
-
|
-
|
-19.03
|
-
|
-0.021
|
1.287
|
2.105
|
-
|
Net margin
|
5%
|
-133.19%
|
-83.27%
|
-
|
-
|
-39.46%
|
-
|
-0.04%
|
2.72%
|
4.99%
|
-
|
EPS
|
0.0600
|
-1.320
|
-0.9000
|
-
|
-
|
-1.500
|
-
|
-0.1200
|
0.0400
|
0.0700
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/9/21
|
3/31/22
|
5/16/22
|
9/20/22
|
12/20/22
|
3/20/23
|
5/8/23
|
8/8/23
|
11/7/23
|
3/12/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-25.8
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
-
|
3/16/21
|
3/31/22
|
3/20/23
|
3/12/24
|
-
|
Last Close Price
3.47
USD Average target price
5
USD Spread / Average Target +44.09% Consensus |
1st Jan change
|
Capi.
|
---|
| -11.48% | 102M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|